NCT03088137 - Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment | Biotech Hunter

Enrollment

118

Participants

Timeline

Start Date

February 8, 2017

Primary Completion Date

August 17, 2018

Study Completion Date

August 17, 2018

Conditions

Infertility, Female

Interventions

DRUG

Follitropin alfa (Gonal-f)

Subcutaneous injection, fixed starting dose 150 IU for 5 days, maximum of 16 days of ovarian hyperstimulation

DRUG

Follitropin alfa (Primapur)

Subcutaneous injection, fixed starting dose 150 IU for 5 days, maximum of 16 days of ovarian hyperstimulation

Trial Locations (3)

AltraVita IVF clinic, Moscow

Perinatal Medical Center, Moscow

Clinical Hospital Lapino, Moscow Oblast